We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
+0.5%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$1.36B
AUM Growth
+$560M
Cap. Flow
+$560M
Cap. Flow %
41.27%
Top 10 Hldgs %
26.83%
Holding
370
New
162
Increased
46
Reduced
29
Closed
131

Top Buys

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$16.2M
2
BIG
Big Lots, Inc.
BIG
+$13.3M
3
MDCO
Medicines Co
MDCO
+$13M
4
MMM icon
3M
MMM
+$12.9M
5
FLTX
Fleetmatics Group PLC
FLTX
+$11.7M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$12.7M
2
GAP
The Gap Inc
GAP
+$10.3M
3
AAPL icon
Apple
AAPL
+$8.41M
4
LRCX icon
Lam Research
LRCX
+$8.28M
5
NFLX icon
Netflix
NFLX
+$8.02M

Sector Composition

Rank Sector Weight
1 Industrials 9.16%
2 Technology 6.03%
3 Consumer Discretionary 6.03%
4 Healthcare 3.16%
5 Communication Services 2.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPN
326
DELISTED
Calpine Corporation
CPN
-69,639
Closed -$1.36M
CVO
327
DELISTED
Cenevo, Inc.
CVO
-12,500
Closed -$344K
CIE
328
CALL
DELISTED
Cobalt International Energy, Inc
CIE
-26,667
Closed -$6.58M
JOY
329
DELISTED
Joy Global Inc
JOY
-47,000
Closed -$2.75M
AEGR
330
CALL
DELISTED
Aegerion Pharmaceuticals
AEGR
-73,700
Closed -$5.23M
OUTR
331
PUT
DELISTED
OUTERWALL INC
OUTR
-65,000
Closed -$4.37M
ARO
332
CALL
DELISTED
Aeropostale Inc
ARO
-250,000
Closed -$2.27M
ARO
333
PUT
DELISTED
Aeropostale Inc
ARO
-320,300
Closed -$2.91M
LF
334
DELISTED
LEAPFROG ENTERPRISES INC.
LF
-50,000
Closed -$397K
GMCR
335
DELISTED
KEURIG GREEN MTN INC
GMCR
-50,000
Closed -$3.78M
GMCR
336
PUT
DELISTED
KEURIG GREEN MTN INC
GMCR
-4,100
Closed -$310K
BRCM
337
DELISTED
BROADCOM CORP CL-A
BRCM
-60,000
Closed -$1.78M
GOMO
338
DELISTED
SUNGY MOBILE LTD ADS
GOMO
-90,000
Closed -$1.85M
XOOM
339
DELISTED
XOOM CORP COM
XOOM
-26,900
Closed -$691K
STRI
340
DELISTED
STR HLDGS INC COM STK NEW (DE)
STRI
-210,558
Closed -$992K
ANN
341
DELISTED
ANN INC
ANN
-82,500
Closed -$3.02M
PWRD
342
CALL
DELISTED
PERFECT WORLD CO LTD SPONSORED ADR REPSTG CL B (CAYMAN ISL)
PWRD
-785,000
Closed -$14M
PWRD
343
DELISTED
PERFECT WORLD CO LTD SPONSORED ADR REPSTG CL B (CAYMAN ISL)
PWRD
-28,500
Closed -$507K
BALT
344
DELISTED
BALTIC TRADING LIMITED COMMON STOCK
BALT
-280,301
Closed -$1.8M
RKT
345
CALL
DELISTED
ROCK-TENN COMPANY CL-A
RKT
-40,000
Closed -$2.1M
MWV
346
DELISTED
MEADWESTVACO CORP
MWV
-20,000
Closed -$727K
AUXL
347
CALL
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
-155,000
Closed -$3.21M
AVNR
348
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
-135,000
Closed -$514K
THI
349
DELISTED
TIM HORTONS INC COM, CANADA
THI
-33,512
Closed -$1.96M
TAM
350
DELISTED
TAMINCO CORP COM
TAM
-60,000
Closed -$1.21M

Similar funds

J. Goldman & Co's Q1 2014 Portfolio in Review

As of Q1 2014, J. Goldman & Co held 370 positions worth $1.36B, up 70% from $796M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

J. Goldman & Co deployed $560M of net new capital in Q1 2014, opening 162 new positions and adding to 46 existing holdings. Its largest new stake was RTX Corp: 224,844 shares worth $16.5M.

By sector, the portfolio is most concentrated in Industrials at 9.2% of assets, up from 8% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was ELONG, INC. AMERICAN DEPOSITARY SHARES, an estimated $2.53M trimmed.

  • J. Goldman & Co's largest Q1 2014 buy was RTX Corp: 224,844 shares worth $16.5M.
  • J. Goldman & Co added most to Medicines Co in Q1 2014, an estimated $13M increase.
  • J. Goldman & Co's biggest Q1 2014 reduction was ELONG, INC. AMERICAN DEPOSITARY SHARES, cutting an estimated $2.53M.
  • J. Goldman & Co fully exited Medtronic in Q1 2014, selling an estimated $12.7M.
  • J. Goldman & Co's ten largest holdings make up 27% of its $1.36B portfolio in Q1 2014.
  • J. Goldman & Co opened 162 new positions and closed 131 in Q1 2014.
  • J. Goldman & Co's portfolio value rose 70% quarter-over-quarter to $1.36B.

Based on J. Goldman & Co's 13F filing for Q1 2014, filed 15 May 2014.